
|Articles|October 1, 2000
Four controversies in pediatric asthma care
Asthma management has come a long way in recent years, but many dilemmas remain: When is the right time to make the diagnosis and start anti-inflammatory therapy? What about growth suppression from steroids? Is an inhaler or nebulizer best for acute attacks?
Advertisement
Newsletter
Access practical, evidence-based guidance to support better care for our youngest patients. Join our email list for the latest clinical updates.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Contemporary Pediatrics
1
FDA approves first gene replacement therapy (Itvisma) for patients 2 years and older with spinal muscular atrophy
2
Druhan Howell, MD, discusses ACAAI tapinarof data for pediatric atopic dermatitis
3
Otsuka submits centanafadine NDA to FDA to treat ADHD in children, adolescents, adults
4
Jonathan Flyer, MD, highlights the LEAD initiative to increase pediatric lipid screenings
5












